Patient Preference and Adherence

Making An Impact in Diabetes Preference and Adherence Research

Diabetes is a significant clinical and economic burden in the United States and worldwide. According to the Centers for Disease Control and Prevention, 37.3 million Americans have diabetes and 96 million have pre-diabetes. The total costs of diabetes were estimated to be $327 billion in 2017, up from $245 billion in 2012. By 2030, diabetes is estimated to cost $414 billion, or 1.69% of gross domestic product. While research of methods that address diabetes management adherence exists, actual adherence to clinical recommendations remains poor. To address this problem, it is important to take a holistic approach to examine reasons for non-adherence from all stakeholders, including patients, prescribers, institutions, and others. Furthermore, a focus on interventional research to address adherence and its impact on short- and long-term clinical and economic outcomes in high-risk populations is necessary as well.